Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

18.53
Delayed Data
As of 9:33am ET
 +0.08 / +0.43%
Today’s Change
11.87
Today|||52-Week Range
23.67
+15.88%
Year-to-Date
No recent news for Osiris Therapeutics Inc.

Today’s Trading

Previous close18.45
Today’s open18.45
Day’s range18.43 - 18.53
Volume3,332
Average volume (3 months)195,319
Market cap$635.4M
Dividend yield--
Data as of 9:33am ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+520.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio147.9
Price/Sales9.15
Price/Book7.55

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.07-0.98%
ANIPANI Pharmaceuticals ...+1.00+1.94%
QUREUniqure NV+0.34+1.24%
XBITXBiotech Inc0.000.00%
Data as of 9:50am ET, 09/03/2015

Financials

Next reporting dateNovember 6, 2015
EPS forecast (this quarter)$0.06
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lode Debrabandere
Chief Financial Officer, Secretary &
Treasurer
Philip R. Jacoby
Corporate headquarters
Columbia, Maryland

Forecasts

Partner Offers